Naloxone
ID: 9594CS25Q0020Type: Solicitation
Overview

Buyer

COURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES OFFENDER SUPV AGCYWASHINGTON, DC, 20004, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/afba69212f87409ab6361e814d2ebe1e/view
Timeline
    Description

    The Court Services and Offender Supervision Agency (CSOSA) is seeking proposals for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray, as outlined in their solicitation. This procurement aims to ensure the availability of this critical medication, which is essential for reversing opioid overdoses, thereby supporting public health and safety initiatives. The contract will be awarded under a firm-fixed price purchase order, with a submission deadline for quotations set for January 7, 2025. Interested vendors can direct inquiries to Matthew Collins at matthew.collins@csosa.gov or by phone at 202-369-7635 for further details on compliance and submission requirements.

    Point(s) of Contact
    Matthew Collins
    (202) 369-7635
    matthew.collins@csosa.gov
    Files
    Title
    Posted
    9594CS25Q0020 AMD 0001.pdf
    This document is Amendment 0001 to Solicitation 9594CS25Q0020 issued by the Court Services and Offender Supervision Agency regarding the procurement of Naloxone. The amendment outlines the acknowledgment requirements for any proposals, which must be communicated via specific methods prior to the deadline. It details the necessary contractor information to be included in submissions, replacing section L.1.2, which now specifies required details such as the contractor's contact information, Tax Identification Number, Unique Entity Identification, Cage Code, and a validity statement for the quotation. Additionally, a new section L.1.3 mandates information about the manufacturer of the quoted product. The amendment emphasizes that acknowledgment of receipt must be submitted with proposals to avoid rejection due to noncompliance. Overall, this document aims to clarify submission requirements and ensure compliance in the procurement process.
    Attachment J-1 FAR 52.212-3 Offeror Reps & Certs.docx
    The document outlines the Offeror Representations and Certifications required for federal solicitations, specifically focusing on commercial products and services. It details the criteria for small businesses, including those owned by economically disadvantaged women and service-disabled veterans, alongside requirements for various certifications, such as compliance with the Buy American Act and prohibitions on the use of certain telecommunications and technologies. The sections emphasize the necessity for offerors to confirm their business status, confirm integrity regarding federal contracts, disclose tax liabilities, report any previous contracts, and observe restrictions related to operations in Sudan and dealings with Iran. Overall, the document serves as a comprehensive guide for prospective contractors to ensure compliance with federal regulations and eligibility for government contracts while maintaining transparency and ethical business practices. The structured format allows offerors to indicate their compliance with specific requirements clearly, ensuring a thorough understanding of obligations under the given solicitation.
    Solicitation 9594CS25Q0020.pdf
    The document outlines a federal solicitation for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray by the Court Services and Offender Supervision Agency (CSOSA). It specifies the required specifications, delivery timelines, and the contractual agreement structure, categorized under a firm-fixed price purchase order. The primary NAICS code for this contract is 325412, indicating it involves pharmaceutical preparation manufacturing, with a small business size standard of 1,300 employees. Key points include the requirement for vendors to submit their quotations by January 7, 2025, and details about the invoice processing via the Department of Treasury's Invoice Processing Platform. The solicitation emphasizes compliance with various federal regulations and clauses surrounding contractor conduct, payment processing, and delivery expectations, ensuring the procurement services align with government standards. The document is structured into sections addressing requisition details, supplies, specifications, delivery instructions, and administrative requirements, guiding potential contractors through the bidding process while ensuring adherence to government procurement policies.
    Lifecycle
    Title
    Type
    Naloxone
    Currently viewing
    Solicitation
    Similar Opportunities
    FMS Cache Rx Products
    Buyer not available
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (ASPR/ORM-SNS), is seeking qualified vendors to supply FMS Cache Rx Products through a Combined Synopsis/Solicitation. The procurement involves a range of pharmaceutical products, including both over-the-counter and prescription medications, with specific requirements for quantities, packaging types, and compliance with regulatory standards. This initiative is crucial for ensuring the availability of essential medical supplies for government facilities, thereby supporting public health services. Interested vendors should contact Terri Reed at terri.reed@hhs.gov or Kimberly Golden at kimberly.golden1@hhs.gov for further details and to participate in the bidding process.
    Cable Television and Internet Modem Services
    Buyer not available
    The Court Services and Offender Supervision Agency (CSOSA) is announcing its intent to sole source the procurement of Cable Television and Internet Modem Services, specifically to Comcast Government Services, LLC. This procurement involves the installation of High Definition Cable Television and Internet Modem services at seven CSOSA office locations, addressing the agency's unique requirements that cannot be met by alternative suppliers. The contract is crucial for ensuring reliable communication and information access within the agency, enhancing operational efficiency. The anticipated period of performance for this contract is from March 27, 2025, to March 26, 2026, under a firm fixed price arrangement. For inquiries, interested parties should contact Colin Lee via email at Colin.Lee@CSOSA.gov, as telephonic questions are discouraged.
    Ondansetron 4MG and 8MG
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.
    6505--762-25-2-040-1078 -Tucson CMOP ESCITALOPRAM OXALATE -(VA-25-00049225)
    Buyer not available
    The Department of Veterans Affairs is preparing to procure Escitalopram Oxalate 20mg tablets for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This presolicitation notice, identified by contract number 36C77025Q0169, outlines the requirement for timely delivery of the pharmaceutical product within 10 days after order receipt, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is set aside for small businesses under the NAICS code 325412, with a response deadline of March 13, 2025, at 3 PM Central Time. Interested vendors should submit their quotes via email, including necessary documentation, and are encouraged to monitor SAM.gov for updates.
    15BCTS24Q00000014 SU/MH in Boston, MA
    Buyer not available
    The Department of Justice, through the Federal Bureau of Prisons, is soliciting proposals for Community Treatment Services (CTS) focused on providing outpatient substance use disorder and mental health treatment services for offenders in Boston, Massachusetts. The procurement aims to deliver comprehensive support, including counseling, assessments, and treatment planning, utilizing evidence-based practices such as Cognitive Behavioral Therapy (CBT) and Medication-Assisted Treatment (MAT) to enhance rehabilitation and reduce recidivism. This initiative underscores the Bureau's commitment to improving mental health outcomes for incarcerated individuals and facilitating their successful reintegration into society. Interested contractors must submit their proposals by March 21, 2025, and can direct inquiries to Kia Warner at k1warner@bop.gov or Robert Carroll at r1carroll@bop.gov.
    U.S. CBP, San Diego Field Office Narcotics Destruction
    Buyer not available
    The Department of Homeland Security, through the U.S. Customs and Border Protection (CBP), is seeking proposals for the destruction of approximately 23,000 pounds of seized narcotics at the San Diego Field Office. The selected contractor will be responsible for neutralizing and disposing of these illicit substances in compliance with federal regulations, ensuring they are rendered non-retrievable and environmentally safe, while adhering to the guidelines set forth in the Seized Asset Management Enforcement Procedures Handbook and DEA regulations. This initiative is crucial for maintaining public safety and environmental standards, emphasizing the use of environmentally preferable products in line with the Department of Homeland Security’s “Green Procurement Program.” Interested parties should contact Christopher J. Shaw at christopher.j.shaw@cbp.dhs.gov for further details, as the contract is set for a one-year period following the award.
    Second Chance Act Goods and Services Pre-Solicitation Notice
    Buyer not available
    Presolicitation notice: ADMINISTRATIVE OFFICE OF THE US COURTS is seeking goods and services related to Outpatient Mental Health and Substance Abuse Centers. The federal Judiciary intends to procure treatment services and/or Second Chance Act goods and services for federal defendants and persons under supervision using Blanket Purchase Agreements. The services may include urine collection, counseling, physical examinations, detoxification, residential treatment, and transportation. The goods and services may include cognitive behavioral therapy, child-care, medical services, computer hardware/software, identification, transportation, transitional housing, domestic violence intervention, and job training. The specific services and requirements will be identified in the solicitation for Blanket Purchase Agreements.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    Oxycodone HCL Acetaminophen 325MG National Contract Solitiation
    Buyer not available
    Special Notice DEPT OF DEFENSE is seeking Oxycodone HCL Acetaminophen 325MG through a national contract solicitation. Oxycodone HCL Acetaminophen 325MG is a medication used for pain relief. The place of performance for this procurement is Weatherby, MO (zip code: 63119), USA. For more information, contact Denise Taubman at denise.taubman@dla.mil or 215-737-6877.